Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Melasma and reflectance confocal microscopy: from baseline to treatment monitoring.
Guida S, Longo C, Ronga R, Stabile G, Podo Brunetti A, Bigotto GD, Conforti C, Ciardo S, Cantisani C, Paolino G, Mercuri SR, Nisticò SP, Zerbinati N, Rongioletti F, Pellacani G. Guida S, et al. Among authors: ronga r. Int J Dermatol. 2024 Aug;63(8):1007-1012. doi: 10.1111/ijd.17117. Epub 2024 Mar 6. Int J Dermatol. 2024. PMID: 38448367 Review.
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
Longo V, Della Corte CM, Russo A, Spinnato F, Ambrosio F, Ronga R, Marchese A, Del Giudice T, Sergi C, Casaluce F, Gilli M, Montrone M, Gristina V, Sforza V, Reale ML, Di Liello R, Servetto A, Lipari H, Longhitano C, Vizzini L, Manzo A, Cristofano A, Paolelli L, Nardone A, De Summa S, Perrone A, Bisceglia C, Derosa C, Nardone V, Viscardi G, Galetta D, Vitiello F. Longo V, et al. Among authors: ronga r. Front Immunol. 2024 Jan 18;14:1289434. doi: 10.3389/fimmu.2023.1289434. eCollection 2023. Front Immunol. 2024. PMID: 38304255 Free PMC article.
Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab.
Romano FJ, Ronga R, Ambrosio F, Arundine D, Longo V, Galetta D, Gridelli C, Maione P, Palma V, Damiano V, Verde A, Giacobbe I, Augurio MR, Iengo G, Chetta M, Tarsitano M, Campione S, Failla G, Raucci A, Riccardi F. Romano FJ, et al. Among authors: ronga r. Cancer Diagn Progn. 2023 Jan 3;3(1):44-52. doi: 10.21873/cdp.10178. eCollection 2023 Jan-Feb. Cancer Diagn Progn. 2023. PMID: 36632583 Free PMC article.
Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy.
Vitale MG, Crispo A, Arundine D, Ronga R, Barbato C, Luongo A, Habetswallner F, De Martino BM, Maione A, Eisenwagen S, Vitale G, Riccardi F. Vitale MG, et al. Among authors: ronga r. Front Pharmacol. 2022 Nov 8;13:874028. doi: 10.3389/fphar.2022.874028. eCollection 2022. Front Pharmacol. 2022. PMID: 36425572 Free PMC article.